Wow! 2022 has been an exciting year of new challenges, amazing successes, and incredible opportunities. And we couldn't have gotten through it all without YOU! Before we wrap up the top stories and new features from OncData this year, we want to take time to thank each and every one of YOU: doctors, nurses, medical staff, and all frontline workers for your continued dedication. You continue to inspire us each and every day. THANK YOU!
Over the past year, Oncology Data Advisor has had the privilege of working with many distinguished faculty and medical professionals worldwide. In case you missed any of the best content of 2022, we've put together a list below of the top video interviews and podcasts.
Stay tuned for new and exciting video interviews, exclusive podcasts, webinars, activities, and more throughout 2023!
| In this interview in honor of Multiple Myeloma Awareness Month, Dr. Rahul Banerjee, Assistant Professor at the University of Washington and Fred Hutchinson Cancer Center, and member of the Oncology Data Advisor editorial board, speaks with Dr. Manni Mohyuddin about the importance of designing clinically relevant end points for clinical trials in multiple myeloma. |
| At the 2022 ONS Congress in Anaheim, California, Janet Rowe, RN, and Lisa Vigil Schattinger, MSN, RN, gave a presentation about medical aid in dying and the nurse's role in supporting their terminally ill patients' rights to autonomous decision-making. In this interview with Oncology Data Advisor, Ms. Rowe and Ms. Vigil Schattinger discuss their own experiences with medical aid in dying, explain their work to spread awareness and provide education to the community, and share additional advice for nurses on how to engage patients and families in meaningful conversations about this important issue. |
| Lung cancer is the most common cause of cancer death in the United States and worldwide. To help in the fight to raise awareness for this disease, Oncology Data Advisor™ recently hosted a live expert faculty panel discussion discussing the latest research in immunotherapy and targeted therapy for lung cancer. Watch the video now to hear new insights and perspectives from Beth Sandy, MSN, CRNP, Thoracic Oncology Nurse Practitioner, Abramson Cancer Center, University of Pennsylvania, and Corey Langer, MD, Professor of Medicine, Director of Thoracic Oncology, Hospital of the University of Pennsylvania. |
| In this interview, Oncology Data Advisor Editorial Board member Dr. Rahul Banerjee speaks with Dr. Ben Derman, Assistant Professor of Medicine at the University of Chicago, about his research regarding measurable residual disease (MRD) detection in multiple myeloma and its potential role in guiding treatment decisions. |
| At the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Aamir Ehsan, MD, Medical Director at CorePath Laboratories, spoke with Oncology Data Advisor to delve into the topic of personalized and precise diagnosis of cancer by pathology, a topic that he is passionate about other pathologists and oncologists understanding. |
| In honor of Multiple Myeloma Awareness Month, Dr. Rahul Banerjee, Assistant Professor at the University of Washington and Fred Hutchinson Cancer Center, and member of the Oncology Data Advisor editorial board, spoke with Dr. Urvi Shah about the importance of ensuring proper diet and nutrition, as well as the impact of the microbiome, for patients with multiple myeloma. |
